Biocept Prices 5.0 Million Shares at $1.00 A Share

Biocept, Inc. BIOC revealed that it has priced its public offering of approximately 5.0 million shares at a price of $1.00 per share to the public. According to the company, investors will also get warrants to purchase a maximum of about 3.5 million shares of common stock with an exercise price of $1.30 per share. Biocept said that the warrants were immediately exercisable and have a term of five years. The company added that the offering was expected to close on or about May 4 subject to satisfaction of customary closing conditions. The company indicated that total gross proceeds of the offering were expected to be approximately $5.0 million. The net proceeds were expected to be approximately $4.4 million after giving commissions and offering expenditures. Biocept revealed that it plans to use the net proceeds for working capital and general corporate purposes. Biocept said that H.C. Wainwright & Co. acted as its exclusive placement agent for the offering while ROTH Capital Partners, LLC provided advisory services in connection with the offering. On Friday, shares of the company traded 21.6% lower.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsPress ReleasesGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!